HARG Therapy vs. Stem Cell Conditioned Media: How These Two Hair Regeneration Approaches Really Differ2026.07.05

HARG therapy and stem cell conditioned media are both introduced as “delivering growth factors to the scalp to promote hair growth,” so patients frequently ask, “What is actually different?” and “Is it meaningful to receive both?” When you look at the origin of the components and the entry point of the action, however, these two are more different in concept than they may first appear. At AVAN TOKYO Ginza, we position conditioned media as the mainstay of our hair regenerative medicine options, while also framing HARG therapy and oral/topical medications within the same treatment picture. This article compares HARG therapy and stem cell conditioned media in terms of components, mechanisms of action, and indications, and explains, from the perspective of Dr. Moriwaki, where each treatment fits or where they may be combined.

Key Points

・HARG therapy is a “formulated injectable of extracted growth factors”: a targeted-delivery approach.

・Stem cell conditioned media is “the supernatant of what stem cells actually secrete during culture”: a whole-mixture approach delivering hundreds of molecules.

・From the standpoint of the follicular microenvironment, they are complementary rather than competing.

・Neither HARG therapy nor stem cell conditioned media stops the root drivers of AGA (DHT, genetics); combining with oral/topical medication is realistic.

・Rather than asking “does it work,” the first step is to decide “what should be at the center of my treatment.”

What Is HARG Therapy? A “Growth Factor Cocktail” Concept

HARG therapy is a scalp injection method that became popular in Japan under the name HARG—short for Hair Re-generative therapy. The material used is AAPE (Advanced Adipose-derived stem cell Protein Extract), a freeze-dried, purified powder of the protein fraction contained in adipose-derived stem cell culture supernatant. It is reconstituted and injected into the scalp.

A Standardized Growth Factor Injection

The defining feature of HARG therapy is that growth factors are formulated as a standardized preparation, delivered in a defined amount around the follicles. Representative factors include KGF, IGF-1, and VEGF—all known in basic research to support anagen phase maintenance and dermal papilla angiogenesis. Because the formulation is consistent, lot-to-lot variability is relatively suppressed, which makes dose planning more predictable.

On the other hand, HARG therapy is an “unapproved drug” under Japan’s Pharmaceutical Affairs Act, is not covered by insurance for AGA, and is provided as private-pay treatment. Individual response varies, frequent sessions (often once every 1–2 months, 6+ sessions) are usually required, and the cost tends to be high—points to understand up front.

Relationship with AGA and Its Limits

HARG therapy is often considered as an add-on for patients who have plateaued on finasteride or minoxidil, or for female pattern hair loss (FAGA) where oral options are limited. However, it does not act on the root driver of AGA (5α-reductase activity, DHT sensitivity), so HARG therapy alone is not designed to fully halt progression. Guidelines from the Japanese Dermatological Association similarly assume combined use with antiandrogen therapy.

How Stem Cell Conditioned Media Differs — Delivering the Secretome “As Is”

As explained on our hair regenerative medicine article index, stem cell conditioned media refers to the supernatant of the culture medium (conditioned media) that contains what cells such as adipose-derived stem cells or umbilical cord-derived stem cells physiologically secrete under defined culture conditions.

Delivering the “Full Secretome”

Unlike HARG therapy, which purifies and formulates specific factors, conditioned media delivers the whole secretome as it is. It contains not only growth factors such as KGF, IGF-1, VEGF, HGF, and TGF-β, but also cytokines, exosomes, miRNAs, lipids, and extracellular matrix proteins—hundreds of molecules in total. Rather than “high concentrations of one or two specific factors,” the concept is “reproducing the signaling environment around stem cells in the form of a supernatant.” From the standpoint of rebuilding the follicular microenvironment (niche), this broad spectrum is considered a reasonable approach.

Lot Variability and Quality Control

The weakness lies in the fact that composition can vary with cell source, donor, culture conditions, and passage number. Even labeled the same “adipose-derived stem cell conditioned media,” contents are not identical across manufacturing facilities and processes. At AVAN TOKYO Ginza, we use products with verifiable notifications under Japan’s Act on the Safety of Regenerative Medicine, and adopt only lots that can clearly present quality controls such as sterility testing, mycoplasma testing, and endotoxin testing. Patients, too, should ask “which facility made this, and what testing was done.”

Choosing Between HARG Therapy and Stem Cell Conditioned Media in Practice

“Targeted Delivery” vs. “Whole-Mixture Delivery”

The essence of comparing the two lies in the difference between “delivering standardized components in a targeted way” and “delivering what cells actually secreted as a whole.” The former has the strength of compositional consistency; the latter has the strength of breadth of components and reproduction of the follicular microenvironment. Rather than one being better, it is more accurate to say the two play different roles depending on treatment goals and patient background.

Neither Halts the Root Cause of AGA

An important premise: neither HARG therapy nor conditioned media halts the fundamental driver of AGA—5α-reductase activity itself. In progressive AGA, the realistic design is a role division: control progression with oral finasteride/dutasteride while conditioning the follicular microenvironment with cell-derived components. It is better positioned as one part of hair regenerative medicine as a whole rather than a stand-alone cure.

Individual response varies; the reaction depends on AGA stage (Norwood classification), age, and remaining follicular reserve. Rather than promising “this many sessions will grow hair,” evaluating around 3–6 months and revising the plan when response is limited is the honest way forward.

Frequently Asked Questions

Q. Which is more effective, HARG therapy or stem cell conditioned media?

There is no simple “one is better.” HARG therapy is a standardized formulated injectable; conditioned media delivers the whole secretome. Concepts and indications differ. Neither halts the root cause of AGA, and both are treatments that reach their full potential when combined with oral or topical therapy.

Q. How many conditioned media sessions are typically needed?

Given the hair cycle, a common design is several sessions every 2–4 weeks during induction, followed by longer intervals for maintenance. Because optimal frequency varies with disease stage, age, and lifestyle, we personalize the plan at the first consultation.

Q. Can I switch from HARG therapy to conditioned media?

Yes. Many patients transition to conditioned media alone or combined with oral/topical medications, based on prior treatment history and response. When switching, we recommend observing progress over at least a few months.

Q. Are there side effects or precautions?

Transient redness, bruising, or mild swelling from scalp injection may occur; allergic reactions are rare but reported. Patients with atopic dermatitis, autoimmune disease, pregnancy, or breastfeeding should always share this in advance so we can carefully consider indication.

Q. Is it covered by insurance?

Both HARG therapy and conditioned media for AGA/hair regeneration are private-pay and not covered by insurance. Please review not only per-session cost but also the total maintenance cost in advance.

──────────────

Supervising physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate holder

──────────────

📍AVAN TOKYO 銀座 毛髪再生医療

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt available

Inquiries welcome via DM / LINE / Website / Phone.